Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors

S. Feola, C. Capasso, M. Fusciello, B. Martins, S. Tähtinen, M. Medeot, S. Carpi, F. Frascaro, E. Ylösmaki, K. Peltonen, L. Pastore, V. Cerullo

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number1457596
JournalOncoImmunology
Volume7
Issue number8
Number of pages10
ISSN2162-402X
DOIs
Publication statusPublished - 2018
MoE publication typeA1 Journal article-refereed

Fields of Science

  • breast cancer
  • cancer epitopes
  • cancer vaccines
  • checkpoint inhibitors
  • immunotherapy
  • melanoma
  • oncolytic vaccines
  • oncolytic viruses
  • therapeutic antibodies
  • therapeutic vaccination
  • NEGATIVE BREAST-CANCER
  • T-CELL RESPONSES
  • SUPPRESSOR-CELLS
  • PD-1/PD-L1 INTERACTIONS
  • IMMUNOTHERAPY
  • RESISTANCE
  • COMBINATION
  • PATHWAYS
  • THERAPY
  • VIRUSES
  • 3122 Cancers
  • 317 Pharmacy

Cite this